Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Prediction: These Could Be the Best-Performing Growth Stocks Through 2030


When it comes to investing in the right companies for your portfolio, you need to ensure you select businesses that you understand and have the competitive advantages, financials, and leadership to drive lasting growth.

If you're looking for growth stocks that have what it takes to perform well for investors not just now but over the next five years and beyond, there are multiple contenders to consider. Here are two that look like excellent additions to a long-term investor's portfolio.

Vertex Pharmaceuticals (NASDAQ: VRTX) isn't a household name like some other businesses in the healthcare industry, but it should be a strong contender for the long-term investor looking for a profitable company on a strong growth trajectory. For years, Vertex has been the leader in the cystic fibrosis therapeutics market.

Continue reading


Source Fool.com

Vertex Pharmaceuticals Inc. Stock

€420.05
-1.510%
We can see a decrease in the price for Vertex Pharmaceuticals Inc.. Compared to yesterday it has lost -€6.450 (-1.510%).
With 60 Buy predictions and 2 Sell predictions Vertex Pharmaceuticals Inc. is one of the favorites of our community.
As a result the target price of 440 € shows a slightly positive potential of 4.75% compared to the current price of 420.05 € for Vertex Pharmaceuticals Inc..
Like: 0
Share

Comments